Timothy X. Pham

Array ( [id] => 4346949 [patent_doc_number] => 06284795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Sulfonamide compounds and methods of treating atherosclerosis and restenosis' [patent_app_type] => 1 [patent_app_number] => 9/376268 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5592 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284795.pdf [firstpage_image] =>[orig_patent_app_number] => 376268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186903 [patent_doc_number] => 06150523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Process for preparing imidazoquinolinamines' [patent_app_type] => 1 [patent_app_number] => 9/375587 [patent_app_country] => US [patent_app_date] => 1999-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8621 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150523.pdf [firstpage_image] =>[orig_patent_app_number] => 375587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4160203 [patent_doc_number] => 06156897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Method for purifying 20(S)-camptothecin' [patent_app_type] => 1 [patent_app_number] => 9/375050 [patent_app_country] => US [patent_app_date] => 1999-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 5962 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156897.pdf [firstpage_image] =>[orig_patent_app_number] => 375050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4422191 [patent_doc_number] => 06225346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Tyrphostin like compounds' [patent_app_type] => 1 [patent_app_number] => 9/372395 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16005 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225346.pdf [firstpage_image] =>[orig_patent_app_number] => 372395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586192 [patent_doc_number] => 06358965 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Use of benzoylalkyl-1,2,3,6-tetrahydropyridines' [patent_app_type] => B1 [patent_app_number] => 09/331524 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5152 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358965.pdf [firstpage_image] =>[orig_patent_app_number] => 09331524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292327 [patent_doc_number] => 06235758 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Indole derivatives as 5-HT receptor antagonist' [patent_app_type] => 1 [patent_app_number] => 9/359606 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23551 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235758.pdf [firstpage_image] =>[orig_patent_app_number] => 359606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4322908 [patent_doc_number] => 06248904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof' [patent_app_type] => 1 [patent_app_number] => 9/357952 [patent_app_country] => US [patent_app_date] => 1999-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 36815 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248904.pdf [firstpage_image] =>[orig_patent_app_number] => 357952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4298487 [patent_doc_number] => 06184384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Dechlorination of pyridines in acidic, zinc-containing mediums' [patent_app_type] => 1 [patent_app_number] => 9/354279 [patent_app_country] => US [patent_app_date] => 1999-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4292 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184384.pdf [firstpage_image] =>[orig_patent_app_number] => 354279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237869 [patent_doc_number] => 06143767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Piperidinylamino tricyclic compounds as substance P antagonists' [patent_app_type] => 1 [patent_app_number] => 9/351011 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7260 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143767.pdf [firstpage_image] =>[orig_patent_app_number] => 351011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409927 [patent_doc_number] => 06300338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases' [patent_app_type] => 1 [patent_app_number] => 9/348916 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24338 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 406 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300338.pdf [firstpage_image] =>[orig_patent_app_number] => 348916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4090350 [patent_doc_number] => 06133307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists' [patent_app_type] => 1 [patent_app_number] => 9/341027 [patent_app_country] => US [patent_app_date] => 1999-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5965 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133307.pdf [firstpage_image] =>[orig_patent_app_number] => 341027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486147 [patent_doc_number] => 06365738 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Preparation of heterocycles using 1,3-dihalopropenes' [patent_app_type] => B1 [patent_app_number] => 09/342294 [patent_app_country] => US [patent_app_date] => 1999-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3210 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365738.pdf [firstpage_image] =>[orig_patent_app_number] => 09342294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1532942 [patent_doc_number] => 06410505 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Dimeric non-azo naphthalimides and uses for the same' [patent_app_type] => B1 [patent_app_number] => 09/438306 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5807 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410505.pdf [firstpage_image] =>[orig_patent_app_number] => 09438306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4382835 [patent_doc_number] => 06303784 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Pharmaceutical aminophosphonic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 9/331385 [patent_app_country] => US [patent_app_date] => 1999-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9556 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303784.pdf [firstpage_image] =>[orig_patent_app_number] => 331385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291931 [patent_doc_number] => 06235734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy' [patent_app_type] => 1 [patent_app_number] => 9/297109 [patent_app_country] => US [patent_app_date] => 1999-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22782 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 373 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235734.pdf [firstpage_image] =>[orig_patent_app_number] => 297109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4382895 [patent_doc_number] => 06294534 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Spiropiperidine derivatives as melanocortin receptor agonists' [patent_app_type] => 1 [patent_app_number] => 9/329814 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15207 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294534.pdf [firstpage_image] =>[orig_patent_app_number] => 329814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406772 [patent_doc_number] => 06271245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Hydroxamic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 9/322688 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13224 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271245.pdf [firstpage_image] =>[orig_patent_app_number] => 322688 [rel_patent_id] =>[rel_patent_doc_number] =>)